Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
1984 | 1 |
2010 | 1 |
2024 | 0 |
Search Results
2 results
Results by year
Filters applied: . Clear all
The following term was not found in PubMed: hNCR3LG1
Page 1
Transdermal nitroglycerin in angina pectoris.
Am J Cardiol. 1984 Sep 1;54(6):471-6. doi: 10.1016/0002-9149(84)90233-9.
Am J Cardiol. 1984.
PMID: 6433687
After daily therapy with 30-cm2 patches of TGTN for 1 to 2 weeks, exercise tolerance was similar to that seen during daily placebo therapy. These results suggest that TGTN patches are of inadequate size to produce 24-hour antianginal protection. ...
After daily therapy with 30-cm2 patches of TGTN for 1 to 2 weeks, exercise tolerance was similar to that seen during daily pla …
Standard versus low-dose transdermal nitroglycerin: differential effects on the development of tolerance and abnormalities of endothelial function.
Uxa A, Thomas GR, Gori T, Parker JD.
Uxa A, et al.
J Cardiovasc Pharmacol. 2010 Oct;56(4):354-9. doi: 10.1097/FJC.0b013e3181ed2dae.
J Cardiovasc Pharmacol. 2010.
PMID: 20588187
Clinical Trial.
Study 1 randomized six healthy volunteers to receive 0.6 mg/h or 0.05 mg/h TGTN in a crossover design study (6-day washout period) with measurements of heart rate, blood pressure, radial artery waveforms, and aortic augmentation index taken at baseline and 1, …
Study 1 randomized six healthy volunteers to receive 0.6 mg/h or 0.05 mg/h TGTN in a crossover design study (6-day washout per …
Item in Clipboard
Cite
Cite